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About the 
research
In contrast to Europe, the Asia-Pacific region is typified by 
diverse approaches to healthcare amongst countries with 
a range of different political and economic backgrounds—
countries that are thought of as high income mix with others 
with significant growth potential and with those that have seen 
recent rapid growth. As a consequence countries in the region 
lie at varying stages along the epidemiological transition—
the movement from infectious diseases being the primary 
healthcare burden on a country to non-communicable diseases 
(NCDs).
 This report, The shifting landscape of healthcare in Asia-
Pacific: A look at Australia, China, India, Japan, and South 
Korea, written by the Economist Intelligence Unit (EIU) and 
supported by Janssen, seeks to compare and contrast the 
challenges and opportunities arising from the disease burden 
in the region. It also aims to identify best practices that might 
be shared to improve the support offered to people with 
non-communicable disease and infectious disease across five 
countries.
The report draws on in-depth desk research and interviews 
with the following healthcare officials and experts:
Professor Mohammed Ali, associate professor, Hubert 
Department of Global Health, Rollins School of Public Health, 
Emory University 
Professor Sanchia Aranda, president-elect, Union for 
International Cancer Control
Professor Malcolm Battersby, director, Human Behaviour and 
Health Research Unit, Flinders University 
Professor Christine Bennett, dean, School of Medicine, Notre 
Dame University
Professor Juliana Chan, CEO, Asia Diabetes Foundation 
Changbae Chun, general director, Korea Foundation for 
International Healthcare
Professor Aikichi Iwamoto, chair, National HIV Surveillance 
Committee of Japan 
Professor Lixin Jiang, National Centre for Cardiovascular 
Disease, Beijing
Blessina Kumar, chair, Global Coalition of TB Activists 
Dr Vivian Lin, director of health sector development, WHO 
Western Pacific
Professor Gordon Liu, professor of economics, National School 
of Development, Peking University, and director, China Centre 
for Health Economic Research, Peking University
Professor Chee Ng, director, Asia-Australia Mental Health, 
University of Melbourne
Dr Preetha Reddy, managing director, Apollo Hospitals Group
Dr Srinath Reddy, president, Public Health Foundation of India
Dr Shaukat Sadikot, president-elect, International Diabetes 
Foundation
Kenji Shibuya, head, Department of Global Health Policy, 
University of Tokyo
Kin-ping Tsang, chair, International Alliance of Patients’ 
Organisations
The report was written by Paul Kielstra and edited by Charles 
Ross. Elly O’Brien from Bazian, an EIU healthcare business, 
provided research support. We would like to thank all 
interviewees for their time and insight.
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Executive 
summary
Healthcare in Australia, China, India, Japan, and 
South Korea has seen substantial success, with 
life expectancy rising markedly over the past two 
decades in each country. In health, however, the 
playing field never stays constant with changing 
risks presenting challenges for each country. This 
study looks at current and likely future disease 
loads for these five countries as well as how 
healthcare systems are set to cope with them. Its 
key findings include:
Non-communicable diseases already dominate 
the current health burden in the five countries 
in this study. Traditionally, communicable 
diseases are associated with developing countries 
and non-communicable diseases (NCDs) with 
developed ones. Japan, Australia, and South 
Korea made the epidemiological transition to an 
NCD-dominated health burden some time ago.  In 
recent years, China has joined them, with 85% of 
its mortality coming from NCDs in 2010. Even in 
India, a majority of deaths (53%) came from this 
group of diseases and the figure is likely to grow.  
Communicable diseases inevitably remain a 
potential threat to all countries, and an ongoing, 
widespread challenge to health systems in India 
and China, but the main health burden is, and 
increasingly will be, NCDs.
The impact of specific NCDs affecting the 
five countries vary greatly, with China and 
India now the worst affected. A common 
set of risks accounts for much of the growth 
in the number of NCDs, including: ageing; 
unhealthy lifestyle choices around smoking, 
diet, and exercise; environmental pollution; 
and urbanisation. The extent of these risks, 
however, varies greatly between countries so 
that the specific NCDs affecting populations also 
differ markedly. Excessive salt consumption, for 
example, elevates the number of strokes in East 
Asian countries while excessive caloric intake 
means that heart disease is a bigger problem in 
Australia. Air pollution, meanwhile, is driving up 
chronic obstructive pulmonary disease (COPD) 
and lung cancer incidence in China and India.  
Currently, the voluntary and involuntary risks 
experienced in developing countries are exacting 
a heavier price than those in developed ones: 
according to the WHO, in South Korea, Japan, 
and Australia, the combined probability of dying 
from cancer, heart disease, diabetes, and COPD 
between the ages of 30 and 70 is just over 9%.  In 
China, though, it is 19% and in India 26%.
Mental illness is too often an unrecognised 
part of the burden. Mental illness is a significant 
NCD, but, because it is directly responsible for 
few deaths, mortality data tends to hide the size 
of its impact. In terms of total years lived with 
disability by a population, though, the health 
burden is huge—between 20% and 30% of the 
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total. Service provision for those with these 
conditions is usually insufficient. Although 
China and India are beginning reforms in this 
area, health care personnel and infrastructure 
remain insufficient to meet patient need. Japan 
and Korea, meanwhile, remain wedded to care in 
isolated hospitals rather than the community-
based provision which is current best practice. 
Although Australia has gone furthest in the right 
direction, it still has a long way to go.
The NCD challenge requires patient-centred, 
accessible healthcare systems. Most healthcare 
systems were developed for, and are still best-
suited to, acute care. At our current state of 
medical knowledge, though, NCDs are largely 
chronic conditions which require long-term 
management. A system capable of meeting 
this challenge well needs to: give appropriate 
attention to cost effective prevention as many 
NCDs are preventable; be accessible so that 
care will be more than sporadic and episodic; 
provide patient-centred care, in which healthcare 
providers support patients to manage their own 
conditions rather than dictating from above; and 
be integrated so that it can provide each patient 
with coherent, customised care—a need typically 
best serviced by a strong emphasis on primary 
care. Such a system would benefit not only 
those with NCDs, but describes the type of care 
which experts in communicable disease such as 
tuberculosis and HIV also advocate.
None of the healthcare systems in this study 
meet this ideal and several are worryingly ill-
suited to face their current healthcare burden. 
Each of the countries covered has weaknesses:
l Australia—Although it has strong assets 
within its healthcare system, these require 
integration around the patient rather than 
exhibiting a provider focus. Currently patients 
can find it difficult to navigate the complexity.
l China—The country’s recent healthcare 
reforms have so far failed in their goal to 
establish integrated, patient-centred, accessible 
care. Instead provision typically involves 
episodic, very brief interaction with harried staff 
in hospitals. Moreover, costs remain high and 
frustrations have damaged patient-clinician trust 
to such an extent that two-thirds of Chinese do 
not trust doctors’ professional opinions.
l India—The country’s healthcare system is 
still almost entirely organised around acute 
care to an extent that even the health ministry 
acknowledges that efforts against NCDs are only 
“nascent.” High costs also make regular care 
difficult for much of the population to afford. 
Both these factors make effective chronic care 
extremely difficult: one interviewee estimated 
that half of the country’s 62 million diabetics do 
not even know they have the condition. 
l Japan—Japanese healthcare has many 
strengths, but is doctor-dominated, hospital-
focussed and has a weak role for primary care. 
The result is poorly integrated provision in 
which patients face lengthy waits for very short 
consultations as doctors and specialists are in 
short supply. It is also an open question whether 
the current system is financially sustainable when 
funding relies on a debt-strapped government.
l South Korea—Despite impressive 
improvements in its healthcare system in recent 
decades, South Korea shares some of Japan’s 
flaws, including weak primary care, an over-
emphasis on hospital-based provision, and too 
few clinicians. The quality of care also needs more 
attention and provision for those with mental 
illness is particularly poor given the need.
Initiatives both large and small point to 
changes that can work. There is no simple way to 
create a perfect healthcare system, but diverse 
initiatives in the countries in this study show that 
change is possible in a range of important areas:
l Prevention—Effective prevention involves 
winning people over as well as creating 
conditions which make healthy choices easier.  
This can occur at various levels. In Seoul’s 
Gangdong district, health counselling centres 
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based in the community rather than in healthcare 
facilities are attracting large numbers of citizens 
and having a measurable, positive effect 
on health indicators. At the national level, 
Australia’s anti-tobacco efforts, through decades 
of consistent, coherent activity combining 
education, regulation, and taxation have brought 
down smoking rates from 38% in the mid-1970s 
to 13% today.
l Universal access—China’s healthcare reform 
efforts have, as noted above, substantial 
weaknesses but it would be wrong to overlook 
their successes. The widespread extension of 
insurance has helped allow a substantial increase 
in use of healthcare facilities as well as an 
expansion of basic provision such as vaccinations 
and ante-natal care.
l Patient-centricity—The Flinders Chronic 
Condition Management Programme in Australia 
has created self-management support processes 
that involve true partnership between patient 
and clinician, putting into practice the oft-
espoused wish for patient-centric, integrated 
care. Early studies indicate that it is improving 
healthcare outcomes as well.
l Technology—Information and communication 
technology have important innovations to 
offer medical care. Japanese surgeons and 
diabetologists are using big data to shape 
understanding of best practice. Cardiac surgeons, 
who were pioneers in the effort, have seen 
more than a decade of improved outcomes. IT is 
not limited to well-off countries. In India, the 
Swasthya Slate is a point-of-care device that 
allows healthcare workers to conduct 33 different 
tests on the spot and feed the data to more senior 
clinicians if appropriate.
l Reshaping care—If doctor-delivered, hospital-
based care is too expensive for dealing with 
an NCD-based disease load, what alternatives 
might exist? Long Term Care Insurance in South 
Korea has for several years been providing 
subsidised social care for the elderly and has 
shown the potential for reducing levels of 
social hospitalisation—the long-term housing 
of the elderly in hospitals for lack of a better 
alternative. In India, meanwhile, the Accredited 
Social Health Activist programme has helped 
train 900,000 community health workers in rural 
areas. Maternal and child care have especially 
benefitted. 
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Living longer: The challenge of 
success 1
Any examination of the ability of healthcare 
systems in Australia, China, India, Japan, 
and South Korea to address the substantial 
healthcare needs of their populations should 
begin by recognising that, to a greater or lesser 
extent, each country’s problems are more an 
outcome of success than failure.  
Measured by life expectancy alone, all five 
countries achieved substantial increases in 
mortality between 1990 and 2013. India, China, 
and South Korea’s gains were above the global 
mean rise, with each country adding between four 
and five months to life spans for every year that 
passed in that period. Improvements in Japan and 
Australia were below the global average but their 
progress is inevitably slower as they already have 
the world’s first and third longest national life 
expectancies respectively. (Figure 1)
While all have gained, the routes have differed.  
In India, progress has largely been against acute, 
communicable diseases, in particular diarrhoea, 
lower respiratory infection, and neo-natal 
disorders. When combined, these account for 
over half its gain in life expectancy since 1990.  In 
China, longer lives have come from better care for 
communicable and chronic, non-communicable 
conditions, especially cardiovascular (CVD) and 
chronic respiratory diseases.  The three more 
economically developed countries in this study 
present a different picture again, with progress 
almost entirely centred on non-communicable 
diseases (NCDs), in particular CVD and cancer, 
gains that explain over half the extended life 
expectancy there.
Beyond the obvious, life expectancy figures hold 
another lesson for understanding the healthcare 
burden facing these countries: the extent to 
which conditions within them appear to be 
similar or divergent can shift rapidly on closer 
examination. 
Figure 1: Living longer 
Changes in life expectancy at birth 1990-2013 (years)
Australia China India Japan South Korea
Expectancy 1990 77 68 58 79 72
Expectancy 2013 82 76 66 83 81
Gain 5 8 8 4 9
Areas of most progress CVD
Cancer
Diarrhoea/LRI/other
CVD
Diarrhoea/LRI/other
Neonatal disorders
HIV and TB
CVD 
Cancer
CVD 
Cancer
Source: Institute for Health Metrics and Evaluation, Life Expectancy & Probability of Death, 2014, available from 
http://vizhub.healthdata.org/le/.  Based on WHO Global Burden of Disease figures.
7© The Economist Intelligence Unit Limited 2015
The shifting landscape of healthcare in Asia-Pacific 
A look at Australia, China, India, Japan, and South Korea
The healthcare burden
The epidemiological transition
Developed and developing populations get 
sick and die differently for many reasons but 
one important factor behind the variance 
is that economic development results in an 
epidemiological transition. Poor societies 
typically face a greater burden from infectious 
diseases as a group but the improvements in 
healthcare and health systems that frequently 
accompany higher national income lead to 
gradual progress against such conditions. As 
infectious illnesses recede, NCDs come to the fore 
and remain dominant because humans, a mortal 
species, inevitably die of something. 
All five countries in this study have either 
completed such a transition or are presently in 
the midst of one. The change is long established 
in Australia, Japan and Korea, where roughly 
80% to 90% of deaths came from NCDs between 
1990 and 2010, according to the WHO Global 
Burden of Disease figures1. 
India’s epidemiological transition
Percentage change of Disability Adjusted Life Years (DALYs) in India from 1990 to 2010
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Figure 2
94 99
Red–communicable diseases
Blue–Non-communicable diseases
Green–injuries
China has recently joined the developed world 
along this curve, with NCDs accounting for 85% 
of its mortality in 2010, compared to 74% in 
1990.  India is the only country in the group still 
trailing, but it has passed an important tipping 
point with NCDs growing from 40% of deaths in 
1990 to 53% in 2010. This transition is expected 
to continue, according to Dr Srinath Reddy, 
president of the Public Health Foundation of 
India, who expects “a much sharper rise in NCDs 
here over the next two decades.”
However, the concept of an epidemiological 
transition obscures as much as it shows. 
Infectious disease can remain a health issue, 
irrespective of economic development, and the 
factors behind each country’s transition can 
differ greatly. 
As figure 2 shows, the shift in India’s disease 
burden is as much a result of a decrease in the 
incidence of major communicable diseases (in 
red) as it is due to an increase in NCDs (blue) 
and injuries (green). India’s, as well as China’s, 
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epidemiological transitions may also be far 
from complete according to Mohammed Ali, an 
associate professor in the Hubert Department of 
Global Health at Emory University’s Rollins School 
of Public Health, who noted that large numbers of 
people in those countries are rural residents who 
lack access to healthcare. “There is still a major 
transition to come as people urbanise and their 
chronic diseases are recognised,” he said.
The rise of non-communicable diseases 
The more economically developed nations 
present a similar picture when looking at the 
most common NCDs. Cancer, heart disease, 
respiratory illnesses and diabetes made up the 
largest NCD burden in South Korea, Japan and 
Australia in 2012, according to estimates from 
the WHO (figure 3). 
In comparison, although China has roughly the 
same proportion of deaths caused by NCDs as 
South Korea, Japan and Australia, the specific 
diseases are markedly different. Cardiovascular 
disease accounted for 45% of all deaths in China 
in 2012, with more than half of those attributable 
to NCDs, while cancer’s toll was about half of 
that. The burden of respiratory disease is also 
much higher in China than in wealthier countries, 
accounting for 11.3% of all deaths, the large 
majority of which is from Chronic Obstructive 
Pulmonary Disease (COPD). India’s figures are 
lower because of its much larger communicable 
disease burden, but it still shows a similar pattern 
Figure 3: The rising tide of NCDs 
Percentage of total deaths caused by selected NCDs by country, 2012 WHO estimates
Australia China India Japan South Korea
Cancers 29.5 22.4 7.0 30.3 30.3
Total CVD 30.7 45.0 25.8 29.3 24.5
  Stroke 7.5 23.7 9.0 10.1 10.5
  Ischaemic heart disease 14.5 15.3 12.4 8.6 7.0
Respiratory Disease 6.9 11.3 12.7 6.3 5.2
Diabetes 2.9 2.3 2.3 1.2 4.3
Source: WHO Estimated deaths by cause, May 2014 and EIU calculations
to China, with heart disease and even COPD 
outpacing cancer.
One other striking difference between 
economically developed and emerging countries 
is the age at which NCDs kill. In South Korea, 
Japan, and Australia, the combined probability 
of dying from cancer, heart disease, diabetes, 
and COPD between the ages of 30 and 70 is just 
over 9%. In China this probability is 19% and in 
India, despite the higher numbers dying from 
communicable diseases, the figure is 26%.2 
Mortality is just one measure of disease burden. 
Others, like disability adjusted life years (DALYs), 
take into account both the effect of time lived 
with a disability and of early deaths. This measure 
paints a similar picture to mortality, but it also 
illustrates the impact mental illness is having in 
all these countries (see box-out).
Beyond human suffering, the economic cost 
of the growth of NCDs, especially among the 
young, is likely to have a huge impact on national 
economies. China and India are particularly 
vulnerable, as highlighted by a 2013 study from 
the National Bureau of Economic Research. It 
estimated that the cumulative cost of mental 
illness and the four big NCDs would reach $6.2 
trillion in India between 2013 and 2030, and a 
staggering $27.8 trillion in China, or roughly 
three times its 2013 GDP, due to its higher rate of 
heart disease.3  
9© The Economist Intelligence Unit Limited 2015
The shifting landscape of healthcare in Asia-Pacific 
A look at Australia, China, India, Japan, and South Korea
Key NCD risk factors
Population ageing
Increases in life expectancy combined with 
significant falls in fertility rates in all five 
countries have resulted in marked population 
ageing, a process expected to continue in the 
coming decades.
Japan faces the greatest immediate challenge 
of all five countries, as it has the world’s 
highest median age (47), with nearly a quarter 
of its population over age 65 (figure 4 and 5). 
Australia’s population may be older than those in 
South Korea and China, but these two countries 
are catching up fast. China’s population is 
predicted to have a similar proportion of people 
over age 65 as Australia within two decades. 
As Gordon Liu, professor of economics at the 
National School of Development at Peking 
University (PKU), and director of PKU’s China 
Centre for Health Economic Research, noted, 
“we share most of the reasons for population 
ageing with other countries but our one-child 
policy makes our working age population 
smaller.” China will trail behind Korea, which has 
one of the world’s lowest birth rates—despite 
favourable government policies. India is the 
only country in the group with a fertility rate 
above the replacement level. Nonetheless, while 
its population is ageing slower than the other 
countries’, its increasing life expectancy means 
change will still be perceptible.
Ageing closely correlates with prevalence rates 
of many NCDs and the impact is already showing 
on broad measures of health outcomes. In all five 
of the countries, all-age mortality rates for NCDs 
are either holding steady or increasing but age-
standardised rates—which adjust for the impact 
of older populations—have been dropping. 
This effect is particularly marked in Japan, the 
country with the most aged population. (figure 
6).
Complicating matters further will be higher rates 
of multi-morbidity—or living with and needing 
to manage more than one chronic, usually non-
communicable, disease—an issue that grows 
markedly as populations age. 
Although the older years of these extended 
lifespans—are unlikely to be disease free, they 
will not inevitably be unhealthy. Kenji Shibuya, 
head of the Department of Global Health Policy at 
the University of Tokyo, said data from the Global 
Burden of Disease study “suggest that there is 
a compression of [years of] morbidity across 
the globe.” With proper management, the most 
harmful side-effects of NCDs can often be held 
at bay, but health systems will need to help ever 
more patients to do this as populations age. 
Median age of population
(including forecasts using median fertility projection)
(Years)
Figure 4
Source: UN Population Division, World Population Prospects 2012 
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Percentage of population aged 65 and above
(%)
Figure 5
Source: UN Population Division, World Population Prospects 2012 
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Lifestyle factors
The most frustrating element of many NCDs is the 
extent to which they are preventable through 
healthy lifestyle choices. The details, extent, 
and impact of these poor choices, however, tend 
to vary, helping to explain the differences in 
national NCD burdens (figure 7). 
In all five countries, Global Burden of Disease 
figures indicate poor diet—in particular lack of 
fruit—is the major health risk. 
Other issues, though, set them apart. High salt 
consumption is a particularly acute problem in 
China—Global Burden of Disease data indicate 
Japanese deaths per 100,000 population from NCDs
Figure 6
Source: Global Burden of Disease figures taken from Institute for Health Metrics and Evaluation website, “GBD Compare”, 2013, 
 http://vizhub.healthdata.org/gbd-compare.
0
200
400
600
800
1,000 Age standardisedAll ages
20102005200019951990
that it caused around 10% of all deaths there in 
2010—but is also a major issue in Japan, South 
Korea and to some extent India. Salt engenders 
hypertension—the second leading disease risk 
factor in China and Japan—and is associated with 
stroke, helping to explain why in these countries 
this is the predominant cardiovascular condition 
rather than heart disease.4  
In Australia, total caloric intake is a more 
important issue and this, combined with a lack of 
physical exercise, is rapidly swelling waistlines. 
Over a quarter of adult Australians (28%) were 
classified as obese in 2011, according to OECD 
data. Christine Bennett, dean of the School of 
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Medicine at Australia’s Notre Dame University, 
describes the country’s obesity epidemic as 
“probably the single most important health 
challenge facing Australia today.”
Obesity rates are much lower among the other 
countries in this study, but recent changes in 
diet and transportation, often a result of rapid 
economic development, are causing concern. 
“Obesity is becoming a big issue in Korea, 
especially with the younger generation eating 
junk food,” said Changbae Chun, general director 
Figure 7: Feeding death  
Leading health risks and annual associated annual DALYs per 100,000 people, 2010
Australia China India Japan South Korea
Dietary risks 1553 Dietary risks 3536 Dietary risks 4327 Dietary risks 1555 Dietary risks 1957
High body-mass index 1338 High blood 
pressure
2625 Household air pollution 
from solid fuels
3154 High blood 
pressure
990 Alcohol use 1665
Tobacco smoking 1290 Tobacco 
smoking
2062 Tobacco smoking 3141 Tobacco smoking 985 Tobacco 
smoking
1349
High blood pressure 963 Ambient 
particulate 
matter pollution
1763 High blood pressure 2726 Physical inactivity 
and low physical 
activity
584 High blood 
pressure
1034
Physical inactivity and 
low physical activity
702 Household air 
pollution from 
solid fuels
1502 High fasting plasma 
glucose
1916 High fasting 
plasma 
glucose
941
High fasting 
plasma glucose
1089 Ambient particulate 
matter pollution
1817 High body-
mass index
810
Alcohol use 907 Occupational risks 1647 Physical 
inactivity and 
low physical 
activity
759
Occupational 
risks
825 Childhood underweight 1369
High body mass 
index
816 Alcohol use 1358
Physical 
inactivity and 
low physical 
activity
780 Iron deficiency 1242
Physical inactivity and 
low physical activity
1223
Suboptimal 
breastfeeding
735
Source: Institute for Health Metrics and Evaluation (IHME). GBD Compare
at the Korea Foundation for International 
Healthcare. India currently has the lowest 
obesity rates of all the countries examined, 
but Dr Shaukat Sadikot, president-elect of the 
International Diabetes Foundation, said obesity 
among children is also becoming a major health 
problem there. “Activity levels are way down. We 
used to walk to school, but now a car or school 
bus takes them. We also used to play in the school 
grounds for hours. Now that is gone and extra 
lessons to get great grades have taken its place!” 
he said. 
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Although body mass index levels are not as 
elevated in Asian countries as those in Australia, 
the medical consensus is that people of Asian 
ethnicity are more susceptible than Europeans 
to the negative effects of excess weight.5 This 
greater sensitivity helps explain the rapid growth 
of diabetes in India and China and, along with 
salt consumption, could also help explain the 
proportionally higher burden of cardiovascular 
disease in China compared to more developed 
countries.
Negative lifestyle choices are not inevitable. 
Dr Preetha Reddy, managing director of India’s 
Apollo Hospitals Group, said “it depends entirely 
upon us as a country as to how we can reverse 
this tide with appropriate measures taken now 
and urgently involving all stakeholders.” Changes 
in tobacco use show what might be possible. It 
remains a leading cause of heart disease, cancer, 
and chronic respiratory disease in every country 
in this study, but in the two decades after 1990 
the fall in smoking rates (figure 8) resulted in a 
drop in the health burden which they inflict in 
the countries covered in this study of between 
18% (in India) and 61% (in South Korea) as 
measured in age-standardised DALYs per 100,000 
population. 
Environment-related risks
Economic development is also creating a physical 
environment which is a further driver of NCDs. 
Increases in air pollution help explain the 
elevated levels of respiratory disease in both 
China and India and each individual type of air 
pollution—ambient and household—in these 
countries is responsible for a greater number of 
DALYs per 100,000 people than smoking is in any 
of the wealthier countries, according to Global 
Burden of Disease figures. 
Compounding these problems in developing 
economies is increased urbanisation. New 
migrants to cities often live close to sources of 
pollution, in conditions too unsafe to encourage 
exercise and with poor access to nutritionally 
balanced diets. The proportion of people living 
in cities in China has jumped from 31% to 56% 
over the past 20 years, and the UN predicts 
this will grow to 71% in the next two decades. 
Urbanisation rates in India are lower—they have 
grown from 27% to 33% over the same period 
and are predicted to reach 42%—but the trend 
is the same. “Current urbanisation, which is very 
unplanned and chaotic, will be a major propellant 
of NCDs,” noted Srinath Reddy. 
Communicable diseases—the example 
of tuberculosis
Although NCDs make up the greater part of the 
disease burden in the countries covered in this 
report, the challenge of communicable diseases 
never goes away. China’s struggles with the SARS 
outbreak of 2003 and more recent difficulties in 
South Korea with MERS both show that emerging 
diseases can prove complicated for any country 
to handle, however economically developed. 
Existing diseases can also come back: a rise in 
Figure 8: Reduced tobacco woes 
Percentage of adults who smoke, both sexes
1980 1996 2006 2012
Global 25.9 23.4 19.7 18.7
Australia 30.8 24.1 19 16.8
China 30.4 29.5 23.9 24.2
India 18.9 17.7 15.5 13.3
Japan 36.2 32.1 27 23.3
South Korea 36.1 31.7 25.6 23.9
Source: Marie Ng et al., “Smoking Prevalence and Cigarette Consumption in 187 Countries, 1980-2012,” Journal 
of the American Medical Association, 2014.
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deaths from lower respiratory diseases in Japan is 
an ironic result of population ageing permitted by 
success against NCDs.  
Communicable diseases, though, pose quite 
different problems for a country like India, 
where they remain relatively common, than 
for Australia, where they are more a potential 
than current threat. Examining how individual 
countries have managed one condition—like 
tuberculosis (TB)—can help illustrate these 
differences.
TB is a curable communicable disease, although 
treatment can be long and complicated and 
drug-resistance is a growing problem. India and 
China are both deemed high TB burden countries 
by the WHO and TB is one of the top three causes 
of communicable disease deaths and DALYs in 
both countries. Because of the high prevalence of 
the disease and population size in each country, 
India accounted for 24% of all TB cases in the 
world in 2013 and China for 11%.6  
Both countries have National TB Programmes 
that follow the WHO-supported DOTS strategy—a 
policy combination that involves directly 
observed drug therapy as well as a variety of 
public health commitments on financing and 
treatment availability. Each country is making 
progress against the disease and estimated TB 
prevalence has dropped by over half in both since 
1990. Mortality has seen a similar reduction in 
the same period in India, while it has declined to 
less than one-sixth of the 1990 value in China.7 
However, as Blessina Kumar, chair of the Global 
Coalition of TB Activists notes, weaknesses in 
each country’s approach to TB have created 
substantial drug resistance problems. “Obviously 
they [China and India]are not doing something 
right when it comes to addressing TB, or[they] 
would not have increasing numbers each year of 
multi-drug resistant (MDR) TB,” she said.
In India, poor public treatment, which frequently 
exposes the patient to the widespread stigma 
surrounding the disease, has led to extensive 
use of private doctors for the condition. Until 
recently, these doctors’ practices have been 
largely unregulated and state officials believe 
they frequently use the wrong types and levels of 
medication, thereby inducing further resistance.
Despite the health insurance that now covers 
most of its population, China also has problems. 
Its healthcare coverage is not portable, so large 
migrant populations in urban areas - one of the 
groups most at risk - need to pay in order to be 
tested and diagnosed for TB, which results in 
under-diagnosis. Moreover, hospitals fund much 
of their budgets through drug sales and so often 
mis- or over medicate the disease. 
As a result, each country has seen rapidly 
increasing growth in MDR-TB. In India, the 
number of notified cases has grown from 1,660 
in 2009 to over 25,000 in 2013, although this is 
still far below the 62,000 new cases each year 
which the WHO estimates is the true incidence . 
China’s estimated 54,000 unreported cases each 
year is slightly lower, but it only reported about 
3,000 cases in 2013. The WHO has called MDR TB 
a “health crisis” and Ms Kumar agrees. “With the 
emergence of drug resistant TB, it is becoming 
extremely difficult. Almost every day we struggle 
with ensuring access to treatment for MDR TB 
patients.” Both countries recognise that they 
have a problem but progress has been slow.
TB is much less of a problem in South Korea and 
Japan, but issues remain. South Korea has the 
highest incidence of TB in the OECD, at 97 cases 
per 100,000 population, while Japan’s rate of 
18 cases per 100,000 population is also several 
times higher than most developed countries. 
The WHO classifies both as intermediate-burden 
countries and the difficulty tends to be one of 
legacy.  In most cases, human immune systems 
are able to wall off the TB bacillus, making the 
infection latent and harmless. However, about 
10% of these latent infections eventually become 
active, typically when the immune system is 
compromised. TB was an extensive healthcare 
problem in Korea, especially during the Korean 
War, and it used to be Japan’s biggest killer. Some 
remaining latent infections inevitably activate 
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over time. Once active, those infected are capable 
of infecting others. 
In Korea in particular, although mortality figures 
have fallen, incidence has remained stubbornly 
stable and even began to rise during the previous 
decade, a result in part of a lack of attention 
between 1995 and 2010. In 2011, the government 
quadrupled the budget of its TB programme.  
Even as these countries address their current 
high NCD burden, they cannot afford to ignore 
ongoing TB issues.
Australia has different issues again, with very 
low, steady levels of TB that have stayed at a 
prevalence of around seven to eight cases per 
100,000 since the 1980s. As Australia’s TB 
incidence is mainly confined to immigrants and 
aboriginal Australians, it focuses on outreach to 
high risk groups and has also improved its pre-
immigration screening for the disease.
Although India, and to some extent China, still 
need to address existing disease issues, even 
wealthier countries must remain vigilant lest they 
leave openings which allow illnesses to spread.
In healthcare, what gets measured, 
matters. According to WHO estimates from 
2012, in terms of mortality, the direct 
burden of mental illness appears small 
in the countries in this study (figure 9). 
Almost all the deaths in this category arise 
from alcohol and drug abuse—addiction 
is a sub-category of mental illness in the 
figures. Low mortality is partly because 
classification of data obscures some of the 
problem: suicide, for example, is treated 
separately in global accounts. 
However, the nature of the disease also 
affects the data. Mental illness tends to 
first develop when individuals are young 
and in most cases does not kill but persists 
over time. The figures for Years Lived with 
Disability (YLDs) give a starkly different 
picture to those of mortality and, in each 
of the five countries, between 20% and 
30% of YLDs are from mental illness, with 
most of the burden from depression. In 
terms of DALYs, which balance YLDs and 
early morality, the figures are somewhere in 
between.
DALYs and YLDs were introduced in the 
1990s to measure health burdens along 
with mortality figures, and thus highlighted 
the extent to which this previously little-
acknowledged mental health issue was a 
problem. 
Regardless of the figures, Professor Chee 
Ng, director of Asia-Australia Mental Health 
based at the University of Melbourne, 
said discussion about mental health is 
difficult. “Generally mental health is often 
stigmatised and not an attractive topic, 
unlike cancer or cardiovascular disease” 
says Professor Chee. “It has been hard to 
get the attention of politicians and the 
public even though the facts are there.” 
Similarly, Dr Srinath Reddy said of India, 
“Mental illness is a major problem.  It has 
been swept under the carpet for years but 
sporadic surveys suggest a growing harm.” 
In China and India, the situation remains 
stark, with mental health care largely non-
existent and of a very poor standard. In 
the former, a 2012 Lancet article reported 
that an estimated 173 million people have 
a diagnosable mental health condition, of 
whom 158 million have never received any 
care. China has less than one psychologist 
per half a million people and, although 
it officially has around 1.5 psychiatrists 
per 100,000, only a fifth of these are fully 
qualified. India, meanwhile, has only 
0.3 psychiatrists per 100,000 and one 
Mental Illness: A long ignored NCD gets some 
attention
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psychologist per two million people.10 
Institutional care provision can be even 
more worrying. The title of a recent Human 
Rights Watch report on 24 women’s 
psychiatric hospitals in India—“Treated 
Worse than Animals”—accurately described 
its findings.
Difficulties with mental health care take 
a different form in Japan and Korea. The 
global consensus is now that those who 
are ill in this way should be treated largely 
in the community, not in hospitals. There, 
rather than receiving medical treatment for 
the biological symptoms of their conditions, 
those affected should obtain integrated 
medical, social, and employment services 
to help move toward “recovery”—a state in 
which patients can lead what they consider 
a meaningful life within the larger society.
Japan and Korea have been slow to move 
from the older, psychiatrist-controlled, 
institution-based medical model to a 
community-based, recovery one. The 
number of psychiatric hospital beds in 
Japan has dropped slowly, but at 2.7 per 
100,000 people it’s still nearly 60% higher 
than the next OECD country, and more than 
four times the average. In contrast, the 
number of such beds in South Korea has 
tripled over the last 20 years and the OECD 
has criticized the country for excessively 
long hospitalisations and involuntary 
admissions.11
Professor Ng said that while the situation in 
Australia is comparatively good, a lot more 
needs to be done. “Its mental health system 
supports universal and affordable access 
to quality mental health, pharmaceutical 
and hospital services, while helping people 
to stay healthy through health promotion 
and illness prevention activities,” he 
said. It also has examples of innovative, 
community-based service programmes 
which integrate mental health and other 
social services and foster good cooperation 
between relevant stakeholders. That said, 
“we still have a long way to go to address 
the growing mental health burden,” he 
adds. 
Despite the problems of mental health 
care in most of these countries, Professor 
Ng and others interviewees find reasons 
for optimism. Governments have realised 
that the issue needs addressing, and major 
reforms have recently been announced or 
are taking place in China, India, and Japan. 
Dr Reddy also sees recent Indian reforms 
as a positive development, but he warns 
that “legislation only gives the framework 
but not the capacity to implement. There 
is still a great shortage of psychiatrists, 
psychologists and others.” Nor are problems 
absent in wealthier countries. Professor Ng 
notes, “Progress is being made, but change 
takes time.” 
Figure 9: Matters of the mind: Ignorance is bliss?
Mental health burden as proportion of total using different healthcare measures 2012
Australia China India Japan South Korea
Deaths 1% 0% 0% 0% 0%
DALYs 13% 9% 6% 8% 14%
YLDs 25% 27% 22% 20% 30%
Source: WHO
16 © The Economist Intelligence Unit Limited 2015
The shifting landscape of healthcare in Asia-Pacific 
A look at Australia, China, India, Japan, and South Korea
Underlying the concern about the increase in 
NCDs is an acknowledgement that these diseases 
present particular challenges for most healthcare 
systems, which have historically focussed on 
acute, short-term care. Many NCDs require 
lengthy, potentially life-long management and 
Dr Srinath Reddy notes that effective healthcare 
that can treat such patients “will require a fair 
amount of revamping.”
A system that integrates prevention and 
healthcare, that is centred on empowered 
patients and organised through primary care 
providers has obvious benefits for management 
of NCDs. Furthermore, the basics of this effective 
care are similar for all countries, regardless of 
income, because they revolve around strategy 
more than medical technology. “In a specialist 
system everyone wants the next thing that 
goes bang,” said Professor Sanchia Aranda, 
president-elect of the Union for International 
Cancer Control “But you can improve outcomes 
by systematically applying what we already know. 
You don’t need new toys.”
Prevention
Disease prevention holds obvious attractions but 
sounds easier than it is. It begins with educating 
people about healthy choices. However, as 
Professor Shibuya points out, “changing 
individual behaviour is very hard,” in the face 
of social and environmental determinants. 
Another strategy therefore frequently draws 
more attention. Dr Srinath Reddy says prevention 
needs to be looked at across multiple response 
levels. “A lot of good can be done by population 
measures which don’t have high cost,” he said. 
What does good look like?2
“Population prevention”—or laws, regulations 
and taxes that constrain the ability of individuals 
to make bad health choices—can cost less but 
frequently involves regulation, which can lead 
to resistance. Any prevention efforts can be 
completely undermined when the population is 
not convinced of the need to change. Effective 
prevention therefore also needs to change 
minds so that new laws are seen as an aid to 
better health rather than a hindrance to lifestyle 
choices.
Access
Access to healthcare needs to be comprehensive. 
India and China have the most obvious access 
problems in the countries in this study, especially 
in rural areas. Both have made important efforts 
to make universal healthcare a reality rather 
than a goal but continue to struggle . More 
economically developed countries, also have 
problems. Structures within health services can 
be complex for patients to navigate, according to 
Professor Bennett, sometimes making it difficult 
for them to get “the right care in the right place 
at the right time and over time.”
The patient at the centre
The consensus on effective NCD management is 
that patients must be partners in care rather than 
simply recipients of it. The Kaiser Peramanente 
Triangle (figure 10) estimates that 70% to 
80% of NCD patients could be best served by 
self-management supported by occasional 
consultation with health care providers. Only 
those with more serious complications should 
have more intensive services. The reason is 
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simple, according to Professor Juliana Chan, CEO 
of the Asia Diabetes Foundation. “Patients with 
diabetes will see their doctor three to four times 
a year. That’s only an hour’s treatment: patients 
have to learn how to look after themselves 
with support from their care teams.” Kin-ping 
Tsang, chair of the International Alliance of 
Patients’ Organisations goes further. “Patients 
should be involved at all levels and all points of 
the healthcare sector. Otherwise, healthcare 
professionals and governments may not meet the 
needs and preferences of patients,” he explains. 
Patient empowerment, though widely accepted 
in principle, will require behavioural change 
by both patients and doctors, which can be 
difficult to achieve in practice. Mr Tsang said 
that patients must understand that they are 
“partners and stakeholders” in their care which 
will require more education. Dr Ali adds that 
“health education and literacy alone won’t 
change outcomes—knowing about your illness is 
one thing, but you still need to have the means 
and the motivation to change how you live in 
terms of incorporating healthful activities like 
eating a balanced diet, exercising, and adhering 
to medications and healthcare visits.” Getting 
more engaged patients also requires cultural 
change, says Dr Vivian Lin, director of health 
sector development at WHO Western Pacific: “In 
most countries when people get sick they want to 
be cured; they’re not necessarily going to be very 
strongly oriented towards keeping themselves 
well. People don’t necessarily see disease 
prevention as a priority in their lives.”
Doctors, especially specialists, also need to start 
treating patients as partners, a shift that will be a 
particular challenge for Asian nations, according 
to Mr Tsang. “The culture is that the medical 
doctor and other healthcare professionals are 
king. Patients are not in a horizontal position 
with other stakeholders, but vertical - and lower. 
This needs to change,” he said. 
Patient-centred care also looks at the patient’s 
entire set of medical—and sometimes even 
broader social—needs collectively, in an 
integrated way, rather than treating diseases in 
isolation. 
Primary care focus
The key to achieving effective care coordination 
in every country in this study is for NCD 
management, and healthcare as a whole, to have 
a strong primary care focus. When working well, 
this can assist with opportunistic education 
and early detection as well as overall care 
management. 
Achieving this, though, is not necessarily 
straightforward. Physicians do not always 
understand the needs of NCD patients. Problems 
can also arise from the structure of the health 
system. In several of the countries in this study 
general practitioners do not have a gatekeeper 
role, while patients and peers tend not to think 
highly of their services; in Japan they are not 
even a recognised specialty. Dr Lin explains that 
in such situations, “to develop a primary care 
workforce and get a community to believe that it 
is a quality workforce is not easy.”
What might make matters easier is primary care 
that is not physician-led. Professor Chan explains 
that “doctors have to know how to transfer 
knowledge to, and support, other health care 
professionals, such as nurses who are on average 
four time less expensive,” and are able to free up 
The ‘Kaiser Triangle’, illustrating different 
levels of chronic care
Source: NHS and University of Birmingham.
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physicians for more complex cases. Dr Srinath 
Reddy believes simple technology can also help 
build better primary care. “We don’t need doctors 
for all of this, although they may need to step in. 
Instead, it can be done using technology enabled 
front line health workers who can interface with 
population.” Such shifts, though, can run into 
resistance from doctors worried about their 
status.
This is not just a prescription for NCDs
A growing NCD burden may require a revamping 
of healthcare systems, but the changes are likely 
to help across the board as, broadly speaking, 
such an approach is effective for all conditions, 
including communicable disease. Professor 
Aikichi Iwamoto, chair of Japan’s National HIV 
Surveillance Committee, notes that one difficulty 
in dealing with the HIV/AIDS epidemic in much 
of Asia is “health systems in many countries are 
more adjusted to acute infections where people 
are cured by antimicrobials in five days,” than to 
chronic ones. Similarly, Ms Kumar believes that 
the biggest reason for the weakness of TB efforts 
is that they have been too physician-dominated 
and medicalised. She continues, “we need a 
complete change in how we think about TB, with 
solutions that are not just medical but are more 
people-centred, patient-centred.”
Dr Ali says although such a system is feasible, we 
need “to think in a more integrated fashion as 
we move forward managing the double or triple 
burdens of disease that these countries face in 
an efficient way,” rather than appearing to rob 
resource allocation from other diseases to pay for 
high profile and increasingly high cost NCDs.
Where change is most needed
Each element of an NCD-friendly health system 
can bring some benefit, but evidence shows that 
they work best together. “The direction you have 
to take is integration of prevention, long term 
care, medical care, etc.,” explained Professor 
Shibuya. None of the five healthcare systems this 
report examines has fully created such an ideal, 
and this section examines the major challenges 
facing each. 
Australia
Australia combines one of the world’s longest 
life expectancies with widespread chronic 
disease: 77% of residents have at least one such 
condition. The country has various valuable 
assets to manage its current disease load, 
including an established, universal-access 
healthcare system called Medicare; a strong 
emphasis on primary level care; and a hospital 
system that provides effective treatment for both 
chronic and acute patients. Its healthcare system 
is not an undue economic burden—spending on 
health makes up 11.5% of GDP, slightly over the 
OECD average—but Australia does have several 
notable weaknesses which reformers have been 
trying to address in recent years.
Fragmentation 
According to Professor Bennett, the biggest 
challenge the Australian health system faces 
is connecting the different elements of care 
together, whether it be care in the community, 
in people’s homes or in hospitals. “People need 
help with navigating the complexity and getting 
connected care,” she said.
Part of the issue in Australia comes from 
constitutional divisions that make coordination 
of healthcare intrinsically difficult. The national 
government has responsibility for overall 
national health policy and funding Medicare. 
The latter includes the Medicare Benefit 
Scheme which subsidises general practice and 
medical specialist care out of hospitals and the 
Pharmaceutical Benefits Scheme. Individual 
states are in charge of public health and 
managing public hospitals, while both federal 
and state governments have a role in funding 
hospitals. 
The other driver of fragmentation is too great 
a focus on providers rather than patients. 
This creates confusion for patients and leads 
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to lower spending on prevention, a problem 
common across many developed nations. A major 
government-commissioned review of Australia’s 
healthcare system conducted in 2009 highlighted 
the issue. “Usually the patient...must find a way 
of seeing multiple health professionals while 
navigating across various locations, rather than 
health professionals functioning as a team, 
practising together and providing care around 
the whole needs of a person,” the report says12. 
Professor Bennett, who chaired the commission 
that conducted the review, says this still holds 
true in Australia today.
A lack of political consensus 
The 2009 report initiated substantial political 
discussion on Australian healthcare reform, 
which culminated in a National Health Reform 
Agreement in 2011. The agreement was designed 
to strengthen integration and created a number 
of new bodies to improve healthcare delivery and 
integration, including the Australian National 
Preventative Health Agency. However, a change 
of government in 2013 saw the new cabinet roll 
back or discontinue much of the agreement. As 
Professor Bennett notes, “a challenge when you 
are a healthcare reformer is to make the changes 
that are implemented durable.” This will continue 
to be a problem until politicians agree about the 
best way ahead.
China
The Chinese government has implemented 
extensive healthcare reform in recent years and 
most people can now access at least basic care. 
However, several on-going problems impede the 
effectiveness of healthcare providers in dealing 
with the country’s NCD-heavy disease burden.
Primary care problems
One core element of China’s healthcare reform 
was to move primary provision toward the centre 
of healthcare by encouraging greater use of 
local health centres and clinics, and local county 
hospitals. Investment followed and between 
2009 and 2011, the government spent RMB47.15 
bn (roughly $7.4 bn at the time) on improving 
the infrastructure at 25,000 village clinics, over 
2,000 community health centres, and a similar 
number of county hospitals.13 
Since the reforms began, though, primary 
providers are not seeing the development of 
any gatekeeping or coordinating role. Instead, 
while the number of people going to large, urban 
tertiary hospitals has increased substantially, 
use of local, primary care facilities has been left 
unchanged and first line, county hospitals have 
been underused.14 
The first factor driving this incongruous resource 
usage is a search for quality. According to Mr Liu, 
the large state system employs the best doctors 
in the best hospitals and has long discouraged 
these physicians from having any community-
based practices of their own. “When good doctors 
are all locked into the big state hospitals and 
people see no good ones in the community, most 
people would rather go to the hospital, not just 
for inpatient and outpatient needs, but even for 
follow-up checks and prescriptions,” he said. This 
results in large numbers of frustrated patients 
who wait for short consultations with overworked 
medical personnel, who can see up to 70 or 100 
patients per day.15 “In clinics you see most staff 
and doctors are hungry,” Liu added. “They don’t 
have patients.”
Another driver is monetary. Although most 
Chinese now have some form of health insurance, 
more than 800 million rural and unemployed 
urban residents are covered mostly for inpatient 
care in hospitals, according to Mr Liu.  
Funding also blurs the line between primary 
and other care. Hospitals receive just 9% of 
their income from state subsidies. Most of the 
shortfall comes from mark-ups on drug sales 
and charges for services. This creates incentives 
for hospitals to over-prescribe medication and 
high-cost devices and to offer services that could 
be delivered more cost-effectively in community-
based outpatient clinical settings.16
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Mr Liu said this was a serious issue, particularly 
for NCDs. ”What you need with a chronic disease 
can be best provided by a clinic, but now most 
patients would go to the big hospitals for even 
regular check-ups and prescriptions,” he said. “We 
need a major change in how we organise services 
from hospital-centred to community-based.”
The high cost of healthcare
The expansion of insurance coverage has led 
to a lower proportion of healthcare spending 
coming out of patients’ pockets, but it has not 
solved the cost problem. All major insurance 
programs require substantial co-payments and a 
2013 survey by Horizon Research Consultancy, an 
independent Chinese market research firm, found 
87% of respondents said health care was more 
expensive now than it was before the reforms.17
The rate at which people experience catastrophic 
healthcare expense—defined as having to devote 
more than 40% of disposable income after food 
to medical care—has also remained at around 
13% of the population annually, according to a 
number of academic studies. One of these, for 
the Bulletin of the WHO found, that 7.5% of all 
Chinese “non-poor households” were becoming 
poor as a result. Not surprisingly, these cost 
constraints are resulting in sub-optimal care.18 
A decline in doctor-patient trust
China’s healthcare problems reduce the chances 
for a collaborative relationship between medical 
personnel and patients, and cause enormous 
frustration for the sick. As the China Internet 
Information Portal, a government news 
organisation, put it “doctors and nurses are 
experiencing a crisis, and so is doctor-patient 
trust.”19
This “crisis” is reflected in government figures. 
The number of incidents of patient violence 
against doctors in all Chinese hospitals rose from 
20.6 annually in 2008 to 27.3 in 2012, according 
to the Chinese Hospital Association.
The violence is just the tip of the iceberg of 
declining confidence. A country-wide poll of 
several hundred thousand people by China 
Youth Daily in November 2013 found that 67% of 
respondents did not trust doctors’ professional 
diagnosis or treatment recommendations.20 
The Chinese government understands the 
on-going weaknesses in the system and has 
identified further changes, such as strengthening 
primary care, but continued efforts to build a 
system that can address China’s healthcare needs 
will have to address patient frustrations and 
perceptions as much as supply issues.21
India
Some excellent health care facilities exist in 
India, a number of which commonly feature in 
international case studies on how to provide 
effective, high quality, specialist care accessible 
to rich and poor alike. The Narayana Hrudayalaya 
Heart Hospital, the Aravind Eye Care System and 
three Apollo Reach Hospitals all use innovation, 
cost efficiencies, and cross subsidisation 
to provide care to a wide range of patients, 
regardless of income. 
As successful as they are, these examples are 
the exception in India, where healthcare as a 
whole is struggling to address its current disease 
burden. The key issues India faces are a lack of 
doctors, high costs and an epidemiological shift 
to NCDs, all of which leave the country with major 
healthcare challenges. 
Lack of access to affordable care
The India Planning Commission estimated 
that the public health system, which currently 
provides only a minority of the country’s care, 
lacked 600,000 doctors and 1 million nurses in 
2008. With only 0.6 doctors per 1,000 population 
and 0.7 hospital beds per 1,000 people, numbers 
well below its emerging-market neighbour China 
(1.5 doctors and 2.6 beds per 1,000 people 
respectively), these figures are not surprising. 
Medical personnel are also concentrated in the 
cities, which leaves much of rural India, where 
the majority of the population lives, very poorly 
served. 
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What is available does not come cheap when 
compared to Indian incomes. Although the 
EIU estimates that total per capita healthcare 
spending will be only $72 in 2015, three-quarters 
of that is from private sources. Most of this non-
government spending—82% in 2012 according 
to the WHO—is directly out-of-pocket and the 
Indian government estimates that catastrophic 
healthcare costs drive as many as 63 million 
Indians, or roughly 5% of the population, into 
poverty annually.22
According to EIU data, even a simple check-
up at a family doctor consumes an average of 
36% of monthly personal disposable income, a 
disincentive that has obvious implications for 
prevention and early diagnosis, let alone chronic 
disease management. Dr Sadikot notes that, “In 
India, the number of people with diabetes has 
reached 62 million, but half do not even know 
they have it.”
Lack of readiness for the emerging NCD 
burden
Although NCDs now make up over half of 
India’s disease burden, the healthcare system 
is unprepared to deal with them. The Indian 
government’s new draft National Health Policy 
says that “the effort against the growing burden 
of non-communicable diseases are nascent or 
initial steps [sic], with considerable distance 
to traverse before they become universal in 
outreach.” On mental health, the draft candidly 
admits to “a sad state of neglect.”23 
Dr Preetha Reddy agrees, describing the present 
health system as focussed on acute, episodic 
care. “Preventive care at the primary level is very 
weak; insurance covers inpatient curative care 
primarily,” she said. “Centres for long-term, 
chronic care are just about beginning to be set 
up, but are still largely for episodic treatment, 
like dialysis.”
The private sector could help fill some of the 
healthcare gaps in the secondary and tertiary 
sectors, according to Dr Preetha Reddy. However, 
the large burden healthcare costs place on the 
average Indian and the shortage of trained 
doctors and nurses mean the state will need 
to find a way to pay for any large expansion of 
healthcare. 
The national government is aware of this need. 
It has announced plans to double healthcare 
funding to around 2.5% of GDP and is considering 
declaring health care a fundamental right.24 But 
the government has not said how it will find the 
promised money amid on-going austerity, which 
resulted in a nearly 20% cut to health spending in 
the previous budget. 
Japan 
Japanese healthcare has been an undeniable 
success story since the establishment of universal 
provision in 1961. Not only does the country have 
the world’s longest life expectancy, its healthcare 
spending as a proportion of GDP (10.5%) is close 
to the OECD average. Despite this record, concern 
is growing: in a 2010 poll 74% of respondents 
were somewhat or very worried whether they 
or their family would be able to get high quality 
care when needed.25 Professor Shibuya notes 
that the system developed 50 years ago, when 
the population was young and the economy 
was booming, “now requires a comprehensive 
overhaul.” 
Financial sustainability
Healthcare spending in Japan has risen rapidly in 
the past five years, increasing from 9.6% of GDP 
in 2010 to 10.5% in 2015. Japanese data shows 
that ageing has accounted for about half of the 
total growth in medical expenses since 1990 
and the EIU forecasts that healthcare spending 
will continue to rise in the future, albeit more 
slowly.26 
Although much of Japanese healthcare is 
funded by social payments, about 10% comes 
directly from the government and it is ill placed 
to address rising costs after years of economic 
stagnation.27 Japan’s debt to GDP ratio is 
234% - the highest in the OECD and well above 
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Greece’s (171%), according to the EIU - and 
although recent reforms have tried to place more 
responsibility for healthcare costs on private 
sources, a more efficient healthcare system is 
also needed.
Governance by providers
Traditionally the Japanese government has 
used control of the national fee schedule as its 
main instrument of healthcare policy, leaving 
governance to providers. The resultant, doctor-
dominated environment has not always led to 
ideal levels of provision.28
Japan has a low number of doctors (2.2 per 
100,000) by OECD standards, partly due to 
strong opposition from the medical association 
to expanding their ranks, but one of the highest 
rates of physician consultations—around 14 per 
person annually, or more than one per month by 
everyone in the country. This frequently results 
in long waiting times for short interactions and 
allows little time for the complex cases common 
with NCDs. Certain specialities are also under-
served, including radiology and diabetology, and 
the projected lack of nurses and carers to look 
after the aging population has led to government 
support for research into robots to fill these 
roles.29
A hospital-focussed system
The Japanese healthcare system is far more 
hospital-based than those in other developed 
countries. It had 12.7 acute hospital beds per 
1,000 people in 2014, the highest in the OECD 
and about triple the average. Patients also tend 
to stay longer, with the average stay of 18.5 days 
also the highest in the OECD and almost three 
times the mean. 
Ageing again exacerbates the situation. 
Although the government has been trying 
for nearly a decade to create long term care 
facilities for the aged, hospitals too often remain 
long-term residences for the elderly, which 
is a costly solution. This and unusually long 
stays by international standards for various, 
sometimes minor, ailments has led to an ironic 
situation: despite high bed numbers, ambulances 
often struggle to find space for patients with 
emergencies.
Despite the high numbers of in-patients, 
most hospital activity is actually out-patient. 
Individuals do not require referrals for care and 
primary care has traditionally been blurred with 
secondary and tertiary provision at hospital 
run clinics. Indeed, many of the country’s 
large private hospitals started out as small 
private clinics that grew in size to rival public 
peers.30 General practice is also not a recognised 
medical speciality in Japan and so GPs do not 
play a gatekeeper role, nor facilitate care 
coordination.31 
As a recent OECD report noted, Japan’s aging 
population makes primary care essential. 
“Keeping people healthy, economically and 
socially active will demand a health system that 
offers proactive, coordinated and personalised 
care to individuals with one or more chronic 
diseases. Strengthening primary care will be 
central to meeting these challenges.”32 The lack 
of general care may, for example, explain the 
country’s low rate of diagnosis for hypertension 
and poor control among those who are 
diagnosed.33
Next steps
The government has introduced an extensive 
reform package with a vision for the health 
service in 2025. This will include, among other 
things, a much greater role for prevention, and 
closer integration of medical care, as well as 
medical and social care for an ageing population. 
The roadmap, however, is less clear than the 
desired destination. “The government has passed 
a law, but the big question is who will do what 
and how. Will doctors become GPs? Will they do 
everything, or have specialists? Who will provide 
long-term care? There are major questions to 
be answered. It is a very political process,” said 
Professor Shibuya.
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South Korea
South Korea has built a comprehensive, 
universally accessible health care system very 
quickly, with its population receiving universal 
health care only in 1989 following the institution 
of National Health Insurance (NHI). Treatment 
is not free and co-payments for outpatient 
care range from 30% to 60%, although those 
with lower incomes pay less and a cap exists on 
overall annual spending to prevent catastrophic 
individual costs. The results have been largely 
positive and South Korea has achieved the largest 
increases in life expectancy in recent years of all 
five countries in this study. 
These efforts have not ignored NCDs. South Korea 
was a cancer-control pioneer in the Asia-Pacific 
region. Similarly, nation-wide screening has been 
conducted for a long time for the main NCDs, 
according to Changbae Chun. Nevertheless, as it 
wrestles with its own rapidly ageing population 
and a substantial NCD burden, the country faces 
several important challenges.
A physician-dominated system
Many of the challenges in South Korea’s medical 
system are similar to those in Japan. The number 
of doctors (1.7 per 1,000) is kept very low by 
international standards because of pressure from 
the Korean Medical Association. This results in 
short consultation times. Each doctor sees over 
7,000 patients per year, on average, the highest 
level in the OECD and three times the mean.34 
Similarly, much care is hospital-based, with a 
blurred line between clinics and hospitals: it is 
not uncommon for the clinics to have acute care 
beds. Hospitals stays average 17.5 days, more 
than twice the OECD average, which also reflects 
a more institution-based approach to care, driven 
in part by the country’s pay-for-service funding 
model.
According to Mr Chun, primary care is the biggest 
change needed for better NCD management. 
“At present, most people use hospitals to get 
service for their NCDs. We need a programme 
that emphasises primary care.” Unfortunately, 
primary physicians lack a gatekeeper role in 
an already undifferentiated system and the 
position of primary care has weakened in recent 
years. Moreover, it is unpopular with patients 
who perceive the service available as poor and 
unsatisfactory.35 Large hospitals, which attract 
patients via their out-patient departments, also 
tend to oppose primary care gatekeepers.36 
This is leading to unnecessary hospitalisation 
for NCDs. For example, the OECD reports that 
Korea has one of the highest rates of potentially 
unnecessary admission for COPD and asthma, and 
that admissions for hypertension—a condition 
usually controllable through community-based 
management—have risen steadily and are now 
the fourth highest in the OECD.37
The need to shift from care expansion to quality 
Given its relatively short history of universality, 
South Korea’s healthcare system is a work in 
progress. On-going expansion of NHI coverage is 
driving up costs. Although healthcare spending 
is still below the OECD average as a proportion 
of GDP, total healthcare spending rose at 8% 
per year between 2002 and 2012, more than 
double the OECD average. Looking ahead, current 
government policy favours still further increased 
investment for cancer, heart disease, and stroke.
However, monitoring of quality of outcome 
and even patient-safety is less common than 
in most other developed countries, which can 
lead to some worrying results. For example, 
although its institutions are typically furnished 
with technologically advanced equipment, 
the proportion of people who die within 30 
days of being admitted to hospital for a heart 
attack in Korea is greater than in any other 
OECD country.38 Better quality will not be 
only in the patients’ interests, but also in the 
providers’. South Koreans are also becoming 
better educated healthcare consumers and are 
increasingly looking at quality metrics put online 
by the country’s Health Insurance Review and 
Assessment Service before selecting treatment 
teams, according to Mr Chun.
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Too little focus on mental health 
All five countries in this study under-provide 
care for those living with mental illness, but the 
burden is particularly acute in South Korea. This 
is especially apparent in the frequency of suicide, 
which is the fourth leading cause of death after 
cancer, heart disease, and stroke, according 
to Statistics Korea. The suicide rate, which at 
28.4 per 100,000 is the third largest in the 
world, roughly doubled between 2000 and 2011, 
according to the OECD. 
Similarly, the proportional burden of mental 
illness to the overall load of years lived with 
disability is 30%, which is above that for the 
other countries in this study. Looking at risks, 
alcohol use—often associated with mental illness 
as both cause and effect—leads to more DALY’s 
per capita in South Korea than in any of the other 
five countries covered, and is the second biggest 
health risk after diet identified by Global Burden 
of Disease studies. 
However, rather than providing community-
based, integrated care, South Korea has 
responded with more long-stay institutions. 
Not only is it one of the few countries in the 
developed world to see a substantial rise in the 
number of long-stay psychiatric hospital beds, 
roughly three-quarters of residents in those 
institutions have been involuntarily admitted, 
usually at the formal request of family members.39 
Mental illness clearly requires more attention in 
South Korea.
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No magic formula can instantly create a health 
system ideally suited to the evolving disease 
burdens of any country, including the five in 
this study. Instead, this section looks briefly at 
various ways that different health systems are 
trying to address important elements of their 
current challenges, as well as what lessons these 
experiences might hold.
Prevention that works
The idea of prevention is inherently attractive in 
countries where avoidable NCDs are growing in 
prevalence or already dominate the healthcare 
burden. However, simply telling people what is 
healthy frequently fails to yield any benefit and 
effective strategies require more thought.
Community outreach in South Korea
The Gangdong District of Seoul is achieving 
successful prevention by going into the 
community rather than waiting for individuals to 
access medical care.
In 2007, the district’s local Public Health Centre 
began working with local government and 
community stakeholders to create a model for 
distributed health-counselling centres, which 
were eventually established at 16 of Gangdong’s 
18 Community Service Centres. 
Each counselling facility is run by a nurse, who 
can help individuals over 30 years old to assess 
their NCD risk by doing a five point health check 
including abdominal circumference, blood 
pressure, blood sugar, neutral fat, and HDL 
cholesterol. The nurse can also provide advice on 
Examples of change in practice 3
healthy diets and lifestyle, and refer clients to 
community-based exercise groups or classes, as 
well as to healthcare providers where needed. 
Taking health into the community in this way 
appears to be serving a need previously unmet 
by traditional medical care: 65,000 people have 
registered since the program began, roughly 
one-fifth of the target population. In terms of 
prevention, participants are also listening to the 
advice they receive. Of those registered, 32% 
showed improvement in hypertension and blood 
pressure, as well as weight loss, within the first 
six months. Other local governments in Korea are 
looking to replicate Gangdong’s success.40
Tobacco Control in Australia
Australia has long been at or near the forefront 
of tobacco control. Its first government-funded 
anti-tobacco advertising campaigns began at the 
state level as early as 1971, and the national level 
in 1972. Thereafter it instituted, usually ahead of 
most other countries, the combination of bans on 
advertising and public consumption of tobacco 
now common in much of the world.
Most recently, it was the first jurisdiction in 
the world to mandate the introduction of plain 
packaging for cigarettes—a slightly inaccurate 
term for boxes that have no branding on them 
but do have graphic health messages about the 
dangers of smoking. The country’s cigarette 
prices, already high by international standards, 
are also being increased further through a series 
of four annual excise tax hikes of 12.5% each, 
which began in 2013. 
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Decline in smokers
Smoking prevalence rates for 18 years or older and key tobacco control measures implemented in 
Australia since 1990
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The results have been impressive. In the mid-
1970s, 38% of Australian adults smoked but 
by 2013 just 13.3% of those over 18 smoked 
daily. Meanwhile, Australia’s age-standardised 
mortality rates from lung, bronchial and tracheal 
cancers fell by 26% between 1990 and 2010, 
while those from COPD fell by 38%, according to 
Global Burden of Disease data. 
Teasing out what worked among the country’s 
many tobacco control efforts is difficult. First, 
the precise impact of any specific measure can 
arouse controversy given the economic and 
social stakes. For example, higher tobacco 
taxes can provide an incentive for higher levels 
of smuggling, but the actual extent is a matter 
of debate. Recent industry-funded studies 
by KPMG show a rise in the use of contraband 
tobacco to over 10% of total consumption, but 
the Australian government considers the figures 
flawed.41 
Second, it is difficult to measure the exact impact 
of any individual intervention. For example, 
plain packaging was introduced along with a 
substantial cigarette tax hike. An academic 
analysis found that, while overall tobacco 
consumption declined after the law was changed, 
lower cost cigarettes grabbed a larger part of 
the market.42 Third, as the chart in Figure 11 
of prevalence rates for smokers aged 18 years 
or older shows, the decline in the number 
of smokers seems to be steady rather than 
influenced dramatically by any specific measure.
Taking the longer view, the success of tobacco 
control in Australia points to two key attributes. 
The first is consistency. Smoking rates saw an 
extended pause in their decline in the 1990s 
and, in the years before this, advertising efforts 
against tobacco had slackened and taxes 
were stable. A national government effort to 
reinvigorate the anti-tobacco campaign followed 
and the number of smokers resumed its steady 
drop.44
Just as important has been comprehensiveness. 
According to Dr Bennett, success has come 
from “a multi-pronged approach, with lots 
of different interventions in sequence and 
parallel.” Academic research supports this, with 
one examination of public health strategies to 
combat smoking published in the BMJ Tobacco 
Control journal concluding that “consistent and 
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inescapable messages from multiple sources 
appear to be key to success.”45
The push for universal 
healthcare in China
The Chinese government abandoned piecemeal 
healthcare change in 2009 and began a 
major new reform programme targeting five 
areas: expanding health insurance coverage; 
strengthening the primary care system; 
improving public health provision; establishing 
a compulsory essential medicines list with 
controlled prices; and reforming public hospitals. 
The reforms originally had a budget of $124 
billion, but by 2014 the country had spent around 
$480 billion, with no financial end in sight.
As discussed earlier, these changes have not been 
universally successful. In particular, funding 
systems undermine good intentions in the 
areas of primary care and hospital reform, and a 
similar dynamic appears to be playing out with 
medications.46 
However, some very real gains have been made 
as a result of the reforms. The most frequently 
cited benefit, and what Gordon Liu calls the 
reform’s “great success”, is the now near-
universality of health insurance. As of 2012, 95% 
of the population had some healthcare cover, 
up from just 80% in 2008 and 30% in 2005. The 
government’s goal is to reach 98% by 2015. 
Problems remain, as the health insurance 
benefits are far from comprehensive and many 
Chinese still face high costs. The financial 
benefits are also being felt more in urban 
areas—where insurance companies had a larger 
role even before 2009, and where the benefits 
are more substantial—than in rural ones.47 True 
universality will take time. 
Nevertheless, without these reforms, the 
situation would be far worse. As figure 12 
shows, although out of pocket spending per 
person has been increasing, total per capita 
spending—which includes that by governments 
and insurers—has risen far faster, especially in 
urban areas. Rural residents have seen out-of-
pocket spending growing slightly faster than 
income, but the Chinese living in cities, which is 
roughly half the population, have seen a decrease 
in health costs as a proportion of their overall 
spending.48
The reforms have also resulted in greater usage 
of healthcare facilities and the number of 
doctor visits per person rose from 3.7 annually 
in 2008 to 5.1 in 2012. Similarly, the number of 
hospitalisations per 100 people grew over the 
same period from 8.7 to 13.2, an increase of 
over half.49 Although hospital visits have grown 
much faster than primary provision, a number 
of key basic care indicators have also improved. 
Vaccination rates for measles, diphtheria, and 
tetanus were a bit above 90% before the reforms, 
but are now nearly universal, according to the 
World Bank. The proportion of women who had 
five or more antenatal visits during pregnancy 
also rose from 53% in 2008 to 63% in 2011, 
while the number choosing a hospital delivery 
increased from 90% to 96%, according to data 
from China’s National Health Services Survey.
In both cases, the biggest gains were among 
women who lived in poorer, rural areas, showing 
that Chinese health reform is providing a level of 
better access to health care in places where the 
need has been greatest—a central element of 
universal health care. 
However, as Lixin Jiang of the National Centre 
for Cardiovascular Disease in Beijing notes, there 
is still much work to do. “There has been a lot of 
improvement in the health system, especially 
with the increase in basic insurance, but there is 
also a huge challenge,” she said. 
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Patient Self-Management at 
the Centre
The Flinders Program is an effort to find better 
ways to support patients in their own self-
management of chronic diseases.
It began in the late 1990s to improve the 
coordination of care for patients with major 
chronic conditions and multiple morbidities. 
Part of a broader, multimillion-dollar national 
programme, the first South Australian 
Coordinated Care Trials required a substantial 
amount of input from patients on their medical 
problems and the appropriate goals of their care. 
The degree of coordination they then received 
was based on a mathematical formula that linked 
the number of hours of oversight by a health 
professional to the clinical severity of their 
condition.
It soon became apparent that healthcare 
personnel were not following the formula and 
Professor Malcolm Battersby, director of the 
Flinders Human Behaviour and Health Research 
Unit in South Australia, asked clinicians why. 
They said that it was the ability of patients to self-
manage, not the clinician’s view of the severity 
of a patient’s condition, which defined how much 
co-ordination they were receiving. 
This answer changed the course of the whole 
programme and lead Dr Battersby and his team 
to find ways to better support a patient’s ability 
to self-manage. Their early research showed 
that a generic understanding of what good 
self-management involved, and how to achieve 
that, was missing. As a result, the Flinders 
team researched and defined seven principles 
of effective self-management. Using these 
principles, the researchers then developed tools 
to help clinicians and patients reach this self-
management goal. 
Drawing on cognitive behaviour therapy, the 
resultant Flinders Program begins with a meeting 
between the patient and a relevant healthcare 
worker that uses three different tools to identify 
issues, strategies and goals and to create an 
effective partnership. The first is a questionnaire 
completed by patients, self-rating their ability to 
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carry out twelve elements of self-management. 
The second tool is an interview by the health 
professional designed to explore the same twelve 
questions with a focus on discovering barriers to 
self-management. This process identifies which 
of these elements will become issues on the care 
plan. Finally, both parties complete the Problems 
and Goals Assessment—the third tool—in order 
to understand the biggest issues facing the 
patient. After working through these different 
steps–which usually takes around an hour–the 
two then create a joint care plan with agreed 
goals and interventions to be completed over the 
next year.
This scheme has shown itself adaptable to 
patients from a variety of cultural and socio-
economic backgrounds. On the other hand, 
explained Dr Battersby, there can be a cultural 
difficulty with certain clinicians. “All of us as 
health professionals have been trained to solve 
problems, so it is a bit of a paradigm shift to sit 
down and ask ‘What do you think is the best way 
of doing such and such?’” he said. “That’s why we 
really focus on open-ended questions, listening 
and exploring what the person thinks. Who is in 
control of that interview is important.”
Establishing such a partnership and truly 
listening, however, is essential to supporting 
individuals as they manage their conditions. 
Not only does putting the patient’s views at 
the centre make it more likely that people will 
feel invested in their care plans, it can also 
make those plans more realistic by revealing 
the patient’s own over-riding priorities, which 
may not even be medical. An outside analysis 
of the Problems and Goals Assessments created 
during the programme found that only 70% of 
the issues raised in them related to the main 
medical problem, with the remaining 30% being 
psychosocial and other issues. Downplaying or 
ignoring that 30% is a recipe for failed disease 
management. Dr Battersby said this is the central 
element of self-management support: not to tell 
the patients what to concentrate on and how 
to do better but to “find out what you—as the 
patient—think first, get on your page, prioritise 
what you want to work on and then, sooner or 
later, we’ll try to bring your medical problems 
into it,” and offer to work on them together.
Evidence from research trials so far indicates 
that the Flinders Program leads to improved 
health outcomes in a range of contexts, including 
Australian military veterans with co-morbid 
alcoholism and other psychological issues; 
cancer survivors; people with sleep apnoea; 
and individuals who need to undergo regular 
haemodialysis.50 If results from larger trials 
continue to bear out its worth, the project may 
give concrete meaning to the oft-expressed wish 
for patient-centred care. 
Innovative use of information 
and communication 
technology
For a field that relies so heavily on the application 
of science, healthcare is notoriously poor at using 
innovations from non-medical fields. However, 
two cases in the countries covered by this study 
point to innovative ways that information and 
communication technology (ICT) can help 
medical personnel better address healthcare 
burdens.
Big Data in Japan
In 2000, the Japanese Society for Cardiovascular 
Surgery (JSCVS) and the Japanese Association 
for Thoracic Surgery (JATS) collaborated to 
establish the Japan Cardiovascular Surgery 
Database. It holds comprehensive details of 
issues and complications on every operation 
recorded, allowing detailed analysis of the effect 
of interventions. Although the database started 
out with information from only five reporting 
centres, by 2013 it covered most cardiovascular 
operations in the country.
The aim of the database is to improve quality by 
standardising care around best practice and the 
results have been positive. A study of the first 
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adopters of the programme found that, between 
2004 and 2007, the ratio of patients who died 
within 30 days of their procedures compared 
to the number who would have been expected 
to do so given the complexity of their cases 
declined by 24%. Institutions that had not been 
involved with the database for as long saw less 
improvement during those years, suggesting that 
the outcomes came at least in part from using 
data to improve procedures.51
Other specialities have noticed, according to 
Professor Shibuya. Since 2011, the National 
Clinical Database has been harnessing big data 
in other fields of surgery and this new database 
now covers 95% of all surgeries in Japan. 
More striking—copying another innovation 
originally made by cardiovascular surgeons—by 
2017 medical board certification committees 
will evaluate the clinical practice of new 
applicants and renewals in light of these surgical 
databases.52
The use of big data is not limited to operations. 
The Japan Diabetes Clinical Data Management 
Study Group has, since 2001, been analysing 
information submitted on the care of tens of 
thousands of patients with diabetes to discern 
best practice and improve quality. According 
to Professor Shibuya, this “kind of system has 
changed the mind set of doctors and improved 
population outcomes.” 
Point of care diagnostics in India
Advanced use of technology is not limited to 
wealthier countries. India is turning to mobile 
technology to improve healthcare outcomes. 
It is testing a new portable device, called The 
Swasthya Slate, that piggy-backs on mobile 
telephone networks and enables users to 
conduct 33 different medical tests, ranging from 
detecting dengue fever to monitoring heart rate 
and blood sugar levels, using android-based 
mobile devices. 
The Slate’s particular strength is that it can 
allow contact between a user—either a front-
line health worker or even a patient—and a GP 
or specialist who can quickly review the results. 
The Slate can also give protocol-driven advice on 
steps to take, depending on test outcomes. 
Field test results have been impressive, according 
to its creators. In a trial in a small Punjabi city, 
the device enabled community-based health 
workers to screen four times more pregnant 
women for preeclampsia than had been tested in 
the previous year. The capacity it gave for quicker 
diagnosis also meant all affected individuals 
survived with treatment: in the previous 
year 80% of those diagnosed had died. With 
Norwegian government funding, India is now 
rolling out broader use of the Slate for maternal, 
reproductive, and child health care in parts of 
Jammu and Kashmir.
Although its trial has focussed on a narrow part 
of India’s disease burden, the Slate’s broad range 
of point-of-care tests makes it a highly versatile 
tool to address a wide variety of conditions. Dr 
Srinath Reddy, whose Public Health Foundation 
of India helped develop the device, said its 
“potential for non-communicable diseases is 
huge,” with many of the tests standard for the 
care of chronic conditions. Not only could it help 
community health workers diagnose and assist 
in the management of such conditions, if prices 
fall it could even provide more integrated care 
for patients. For example, a person with diabetes 
might be able to do a range of tests which the 
device itself could communicate to relevant 
specialists. The latter, in turn, could then interact 
with the patient through the device.
Reshaping care
A doctor-dominated, hospital-based healthcare 
system is not ideal, either medically or 
financially, for addressing current and expected 
disease loads in any of the five countries 
covered in this study. Two examples of efforts to 
introduce different systems show the potential of 
innovation, as well as it problems.
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Long-term care insurance in Korea
Faced with a rapidly ageing population and 
the prospect of increasing levels of “social 
hospitalisation”—the costly use of hospitals 
as default long-term nursing facilities—Korea 
introduced mandatory long-term care insurance 
(LTCI) in 2008. Under the scheme, anyone over 
age 65 can apply to have their level of need 
assessed based on their physical and mental 
capacity, not on income. Applicants are classified 
into one of several categories, and those who 
face the sufficient constraints on daily living 
receive economic support based on the scale 
of their difficulties. Funding is given directly to 
providers, all of which are private, and which 
may be either institutional facilities or firms that 
provide services in the home. In both cases there 
is a co-pay (15% for in home services, 20% for 
institutional ones) although subsidies exist for 
those less able to pay.
The LTCI scheme has been successful in a number 
of ways. First, it has fostered a large private 
market, with the number of providers nearly 
doubling between 2008 and 2012. It has also 
remained in surplus, in part by starting with a 
restrictive set of benefits—it does not provide 
rehabilitation services, for example. It also 
began with supporting a small proportion of 
the elderly population—just 3.1%—but this had 
expanded to 5.8% by 2012 and the government 
expects to increase it to 7% by 2017.53
The impact of LTCI on National Health Insurance 
is less clear because LTCI covers largely social 
care while the universal healthcare system 
provides medical cover for the same individuals. 
A study looking at more than three million 
hospitals stays during the period before and 
after the introduction of LTCI found that, for 
those individuals whose LTCI benefits included 
institutional care, the average length of stay 
decreased by around a third—although the 
analysis indicated that this was only partly due 
to LTCI. On the other hand, those whose cover did 
not qualify them for institutional care—the small 
majority of those receiving LTCI benefits—saw a 
slight increase in time in hospital.54 
More surprising, another study found that 
increased spending by LTCI on services for the 
elderly correlated with increased outlay on 
healthcare.55 The problem seems to be a lack of 
coordination between the two systems. Among 
the elderly, coordinated health and social care 
is a necessity: over 90% of LTCI patients have at 
least one chronic condition and home nursing 
visits are the least used of LTCI’s standard 
services because of a lack of systemic assessment 
of the need for such care. Moreover, economic 
incentives make it unappealing for doctors to 
work directly with long-term care facilities.56 
Worse still, they are legally not allowed to provide 
any medical services to these facilities, other 
than prescribing medications to residents. More 
comprehensive management of NCDs would 
require the elderly to contract directly with 
ordinary healthcare providers outside of the 
LTCI.57 For LTCI to truly live up to its potential, 
better integration with healthcare is necessary.
Accredited Social Health Activists in 
India
Since 2005, the Indian government’s National 
Health Mission has been training Accredited 
Social Health Activists (ASHAs) to address poor 
healthcare provision in rural areas. These are 
women chosen by the villages in which they live 
to receive basic training programmes so that they 
can: be a first healthcare contact for the village, 
even able to dispense certain basic medicines; 
promote awareness and provide healthcare 
education for the community; and act as a link 
between the village and the formal healthcare 
system. Although they do not receive a salary, 
ASHAs are paid small amounts for specific, 
individual actions, like bringing a pregnant 
woman to have her baby in a healthcare facility or 
a child in for immunisation. 
The programme is now huge, with roughly 
900,000 trained ASHAs and they have been 
extremely valuable in specific areas. According 
to recent academic research, within three years 
of their introduction into Indian states that had 
the poorest overall health outcomes, ASHAs 
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increased the proportion of children receiving 
certain basic vaccines by 14 to 22 percentage 
points and reduced the number who got no 
vaccinations by up to 16 percentage points, 
depending on the state. The study found that 
their major contribution was raising awareness of 
the need for, and availability of, vaccinations.58 
ASHAs have also done a good job in terms of 
maternal health care, according to Dr Reddy, and 
have been particularly effective in increasing the 
extent of antenatal care used.59
The danger is overestimating what ASHAs as 
a group can do without greater investment. 
Although properly trained ASHAs could make 
a positive contribution to NCD care, a variety 
of studies suggest that the current level of 
medical education for ASHAs is insufficient even 
to complete their present tasks. A substantial 
minority of these workers also feel they are 
already not paid enough for the work they do, 
although this varies by state.60 
ASHAs are an excellent idea and they have 
already brought benefits to Indian healthcare but 
expanding their role will require more money and 
better education.
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Shifting landscape
The five countries in this study are highly 
diverse and it’s therefore no surprise that an 
examination of each nation’s health burdens, 
approach to addressing problems, and ideas for 
change show marked differences. However, a 
number of themes repeatedly appear.
NCDs will be the main challenge of the future. 
Non-communicable diseases already make up the 
majority of the health burden in all five countries 
and dominate it in four, with India likely to catch 
up soon. This does not mean that health systems 
can ignore infectious diseases - that is a recipe 
for their resurgence—but it does mean a greater 
focus on the needs of NCD patients is essential.
All of the health care systems need work in order 
to address this challenge. Health systems in all 
of these nations were created to address acute 
conditions and none has fully made the transition 
to provide the best care for NCDs, or even some 
long-term infectious diseases. The problems are 
most obvious in India and China but wealthier 
countries still have important weaknesses. 
Prevention remains under-used. Prevention is 
difficult, but the large majority of NCDs can be 
stopped before they start. Every country needs 
to find ways to address its distinct set of risks, 
Conclusion
be they fat, salt, underactivity, pollution, or 
tobacco, to name a few. Effective prevention 
means thinking beyond traditional healthcare, 
whether by going into the community or taking 
a whole of government approach that gives a 
consistent set of messages and incentives.
New structures and tools are necessary. The 
region’s largely overworked doctors are too few 
to address current health loads in most countries. 
Doctor-dominated care is also too expensive for 
dealing with large numbers of NCDs. A greater 
focus on primary care is an important first step 
where this is under-used, but is only part of the 
story. Greater use of other health care personnel, 
such as specialist nurses or community health 
care workers, the development of institutions 
better placed to provide care such as long-
term care institutions for the elderly, and even 
non-medical technology can all lead to better 
outcomes at lower cost.
Organisation has to be around the patient not 
the provider. Patient-centred care is too often 
just a pious aspiration. Now it is a necessity in 
order to meet the healthcare challenges facing 
every country. Patients must be given the ability 
to care for themselves as much as possible, 
which will mean them being partners in, rather 
than more or less passive recipients of, care. 
This will require cultural change to varying 
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degrees. In particular, medical practitioners will 
have to learn how to work with, and listen to, 
patients better and the latter will need to take 
responsibility for understanding and managing 
their conditions. Without this, secondary 
prevention—and reduction of the NCD burden—
will be a Herculean task.
Finally, for all the weaknesses of health care 
in each of the five countries, it is important to 
remember that people in every one of them are 
living longer, healthier lives, and improvements 
are continuing in each. The message is not one of 
despair, but the need for change. 
As Dr Lin explains, the current health burden, 
especially the growth of NCDs “is very costly for 
health systems, for individuals, for families, 
for workplaces. We can help make people’s lives 
better. A continuum of care needs to be in place,” 
he said. It’s the transition in our thinking and our 
approach, rather than just an epidemiological 
transition that’s important. We can do better.”
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